Hans Wildiers

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2019-03 Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery in QUALITY OF LIFE RESEARCH
  • 2019-02 Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations in BREAST CANCER RESEARCH AND TREATMENT
  • 2019-01 Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer in CLINICAL DRUG INVESTIGATION
  • 2018-12 Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy in BMC CANCER
  • 2018-12 Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer in BMC CANCER
  • 2018-12 A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer in BREAST CANCER RESEARCH
  • 2018-12 Systematic development of CHEMO-SUPPORT, a nursing intervention to support adult patients with cancer in dealing with chemotherapy-related symptoms at home in BMC NURSING
  • 2018-11 Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer in CLINICAL DRUG INVESTIGATION
  • 2018-08 Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-07 A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer in NATURE GENETICS
  • 2018-06 Breast cancer subtype and survival by parity and time since last birth in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-03 Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors in SUPPORTIVE CARE IN CANCER
  • 2018-02 Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-12 The utilization of formal and informal home care by older patients with cancer: a Belgian cohort study with two control groups in BMC HEALTH SERVICES RESEARCH
  • 2017-12 The footprint of the ageing stroma in older patients with breast cancer in BREAST CANCER RESEARCH
  • 2017-12 Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty in BREAST CANCER RESEARCH
  • 2017-11 Association analysis identifies 65 new breast cancer risk loci in NATURE
  • 2017-10 Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer in LUNG
  • 2017 Research Methods: Clinical Trials in Geriatric Oncology in GERIATRIC ONCOLOGY
  • 2016-12 The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients in BRITISH JOURNAL OF CANCER
  • 2016-04-27 Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer in NATURE COMMUNICATIONS
  • 2016-04 Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 in NATURE GENETICS
  • 2016-02 Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-01 A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators in THE JOURNAL OF NUTRITION, HEALTH & AGING
  • 2015-12 A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients in BMC CANCER
  • 2015-12 Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management in BREAST CANCER RESEARCH
  • 2015-12 Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy in BREAST CANCER RESEARCH
  • 2015-12 The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype in ARCHIVES OF PUBLIC HEALTH
  • 2015-10 Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients in DRUGS & AGING
  • 2015-07 The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2015-07 Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-05-20 A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators in THE JOURNAL OF NUTRITION, HEALTH & AGING
  • 2015-04 Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer in NATURE GENETICS
  • 2014-12 Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors in BMC CANCER
  • 2014-12 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy in NATURE COMMUNICATIONS
  • 2014-12 Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation in NATURE COMMUNICATIONS
  • 2014-12 Fall predictors in older cancer patients: a multicenter prospective study in BMC GERIATRICS
  • 2014-10 Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-07 A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-06 Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study in BREAST CANCER RESEARCH
  • 2013-12 Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer in SPRINGERPLUS
  • 2013-12 Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection? in SPRINGERPLUS
  • 2013-12 Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors in SUPPORTIVE CARE IN CANCER
  • 2013-10 Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer in BREAST CANCER RESEARCH
  • 2013-04 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer in NATURE GENETICS
  • 2012-10 A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-02 Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers in BREAST CANCER RESEARCH
  • 2012-01 High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008) in SUPPORTIVE CARE IN CANCER
  • 2011-12 Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the Netherlands in BMC PUBLIC HEALTH
  • 2011-12 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer in NATURE GENETICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.410569.f", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.418897.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.416477.7", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.17635.36", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.468206.e", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.15667.33", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5596.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5510.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.417829.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.414977.8", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.55325.34", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.414055.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
        "familyName": "Wildiers", 
        "givenName": "Hans", 
        "id": "sg:person.01171555551.42", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_634.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01171555551.42'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01171555551.42'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01171555551.42'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01171555551.42'


    This table displays all metadata directly associated to this object as RDF triples.

    48 TRIPLES      10 PREDICATES      27 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01171555551.42 schema:affiliation Nacc3b2db9a4e417692bb51772a40facc
    2 https://www.grid.ac/institutes/grid.15667.33
    3 https://www.grid.ac/institutes/grid.17635.36
    4 https://www.grid.ac/institutes/grid.410425.6
    5 https://www.grid.ac/institutes/grid.414055.1
    6 https://www.grid.ac/institutes/grid.414977.8
    7 https://www.grid.ac/institutes/grid.416477.7
    8 https://www.grid.ac/institutes/grid.417829.1
    9 https://www.grid.ac/institutes/grid.418116.b
    10 https://www.grid.ac/institutes/grid.418897.b
    11 https://www.grid.ac/institutes/grid.418936.1
    12 https://www.grid.ac/institutes/grid.468206.e
    13 https://www.grid.ac/institutes/grid.51462.34
    14 https://www.grid.ac/institutes/grid.5510.1
    15 https://www.grid.ac/institutes/grid.55325.34
    16 https://www.grid.ac/institutes/grid.5596.f
    17 https://www.grid.ac/institutes/grid.66875.3a
    18 schema:familyName Wildiers
    19 schema:givenName Hans
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171555551.42
    21 schema:sdDatePublished 2019-03-07T14:55
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N13b60a81f7504066b3c6cbf771e46b1e
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset persons
    26 rdf:type schema:Person
    27 N13b60a81f7504066b3c6cbf771e46b1e schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 Nacc3b2db9a4e417692bb51772a40facc schema:affiliation https://www.grid.ac/institutes/grid.410569.f
    30 sgo:isCurrent true
    31 rdf:type schema:OrganizationRole
    32 https://www.grid.ac/institutes/grid.15667.33 schema:Organization
    33 https://www.grid.ac/institutes/grid.17635.36 schema:Organization
    34 https://www.grid.ac/institutes/grid.410425.6 schema:Organization
    35 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    36 https://www.grid.ac/institutes/grid.414055.1 schema:Organization
    37 https://www.grid.ac/institutes/grid.414977.8 schema:Organization
    38 https://www.grid.ac/institutes/grid.416477.7 schema:Organization
    39 https://www.grid.ac/institutes/grid.417829.1 schema:Organization
    40 https://www.grid.ac/institutes/grid.418116.b schema:Organization
    41 https://www.grid.ac/institutes/grid.418897.b schema:Organization
    42 https://www.grid.ac/institutes/grid.418936.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.468206.e schema:Organization
    44 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    45 https://www.grid.ac/institutes/grid.5510.1 schema:Organization
    46 https://www.grid.ac/institutes/grid.55325.34 schema:Organization
    47 https://www.grid.ac/institutes/grid.5596.f schema:Organization
    48 https://www.grid.ac/institutes/grid.66875.3a schema:Organization

    Preview window. Press ESC to close (or click here)